Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H BLUM

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1994
Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanomaA Chachoua, R Oratz, L Liebes, et al.
Cancer|January 28, 1998
A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587)A Y Chang, K Kim, H Boucher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomasJ H Edmonson, L M Ryan, R H Blum, et al.
The New England Journal of Medicine|March 3, 1994
Pain and its treatment in outpatients with metastatic cancerC S Cleeland, R Gonin, A K Hatfield, et al.
Journal of the National Cancer Institute|November 18, 1992
Pharmacokinetics of the cardioprotector ADR-529 (ICRF-187) in escalating doses combined with fixed-dose doxorubicinH Hochster, L Liebes, S Wadler, et al.
The American Journal of Medicine|April 1, 1985
Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breastJ L Speyer, M D Green, N Dubin, et al.
The Cancer Journal From Scientific American|March 4, 2000
Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586)A R Yuen, J Z Fuks, D S Ettinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic studyH Hochster, L Liebes, J Speyer, et al.
American Journal of Clinical Oncology|February 1, 1991
A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancerD T Ransom, D Neuberg, C L Loprinzi, et al.
Cancer Treatment Reports|November 1, 1984
Evaluation of a sequential 5-FU and hydroxyurea combination in advanced bowel cancerA K Kao, F M Muggia, N Dubin, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1994
Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanomaA Chachoua, R Oratz, L Liebes, et al.
Cancer|January 28, 1998
A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587)A Y Chang, K Kim, H Boucher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomasJ H Edmonson, L M Ryan, R H Blum, et al.
The New England Journal of Medicine|March 3, 1994
Pain and its treatment in outpatients with metastatic cancerC S Cleeland, R Gonin, A K Hatfield, et al.
Journal of the National Cancer Institute|November 18, 1992
Pharmacokinetics of the cardioprotector ADR-529 (ICRF-187) in escalating doses combined with fixed-dose doxorubicinH Hochster, L Liebes, S Wadler, et al.
The American Journal of Medicine|April 1, 1985
Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breastJ L Speyer, M D Green, N Dubin, et al.
The Cancer Journal From Scientific American|March 4, 2000
Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586)A R Yuen, J Z Fuks, D S Ettinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic studyH Hochster, L Liebes, J Speyer, et al.
American Journal of Clinical Oncology|February 1, 1991
A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancerD T Ransom, D Neuberg, C L Loprinzi, et al.
Cancer Treatment Reports|November 1, 1984
Evaluation of a sequential 5-FU and hydroxyurea combination in advanced bowel cancerA K Kao, F M Muggia, N Dubin, et al.
Pageof 5